Skip to content
Screener

OnKure Therapeutics, Inc. OKUR Return on invested capital

Return on invested capital at other companies

Pfizer logo
PfizerPFE
6%
Replimune Group logo
Replimune GroupREPL
-118%+1,539pp
IDEAYA Biosciences, Inc. logo
IDEAYA Biosciences, Inc.IDYA
-21.2%-6.9pp
Erasca, Inc. logo
Erasca, Inc.ERAS
-75.9%+17.2pp
Arcus Biosciences logo
Arcus BiosciencesRCUS
-116%+139pp
Tango Therapeutics logo
Tango TherapeuticsTNGX
-57.7%-11.3pp

Other financials

Income statement

See full
Revenue-
Operating income-$15.6M+8.1%
Net income-$15.2M+4.8%
EPS (diluted)-$1.11+6.7%

Balance sheet

See full
Cash & equivalents$192.1M+98.7%
Total debt$409.0K-57.2%
Total equity$184.4M+103%
Total assets$198.7M+98.9%

Cash flow

See full
Operating cash flow-$12.9M+7.6%
CapEx$5.0K-72.2%
Free cash flow-$12.9M+7.7%

Valuation

See full
Market cap$167.65M+94.1%
Enterprise value-$24.04M-731%

Returns & leverage

See full
Return on equity-42.7%
Debt / equity0.0×
Current ratio13.8×+2.6×

Where this comes from

Calculated from OnKure Therapeutics, Inc.’s reported figures.

Based on trailing twelve months.

The source filing: OnKure Therapeutics, Inc.’s 10-Q, filed November 13, 2023. Open the filing →

Filed
Nov 13, 2023, 4:05 PM EST
Fiscal quarter
Q3 FY2023
Calendar quarter
Q3 2023
Accession
0000950170-23-062910

FAQ

What is OnKure Therapeutics, Inc.'s return on invested capital?
OnKure Therapeutics, Inc. (OKUR) reported return on invested capital of -93.3% in Q3 2023.
What does return on invested capital mean?
Net operating profit after tax (operating income taxed at the effective rate) divided by average invested capital (debt plus equity minus cash). Measures the after-tax return on all capital put to work in the business, independent of capital structure.

Ask your AI about OnKure Therapeutics, Inc.'s return on invested capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude